HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 259 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -96.7% | 42 | -96.4% | 0.00% | – |
| Q2 2023 | $122 | -5.4% | 1,182 | 0.0% | 0.00% | – |
| Q1 2023 | $129 | -29.1% | 1,182 | -25.9% | 0.00% | – |
| Q4 2022 | $182 | -99.8% | 1,596 | +0.4% | 0.00% | – |
| Q3 2022 | $98,000 | -8.4% | 1,589 | +18.7% | 0.00% | – |
| Q2 2022 | $107,000 | -24.1% | 1,339 | -0.4% | 0.00% | – |
| Q1 2022 | $141,000 | -2.1% | 1,344 | +0.4% | 0.00% | – |
| Q4 2021 | $144,000 | +396.6% | 1,339 | +409.1% | 0.00% | – |
| Q3 2021 | $29,000 | +61.1% | 263 | +40.6% | 0.00% | – |
| Q2 2021 | $18,000 | +5.9% | 187 | 0.0% | 0.00% | – |
| Q1 2021 | $17,000 | +142.9% | 187 | +96.8% | 0.00% | – |
| Q4 2020 | $7,000 | -100.0% | 95 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $83,469,000 | +834590.0% | 1,074,512 | +292682.6% | 0.25% | – |
| Q3 2019 | $10,000 | – | 367 | – | 0.00% | – |
| Q2 2019 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,462,634 | $175,978,000 | 7.18% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,221,585 | $114,954,000 | 6.73% |
| JW Asset Management, LLC | 270,775 | $7,373,000 | 6.49% |
| KOPP INVESTMENT ADVISORS LLC | 104,462 | $2,845,000 | 5.23% |
| 1492 Capital Management LLC | 171,621 | $4,673,000 | 4.56% |
| Avoro Capital Advisors LLC | 4,000,000 | $108,920,000 | 4.54% |
| Paulson & Co. | 8,170,700 | $222,488,000 | 4.46% |
| Rhenman & Partners Asset Management AB | 1,025,000 | $27,911,000 | 3.50% |
| Redwood Investments, LLC | 1,376,066 | $37,470,000 | 2.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 218,000 | $5,938,000 | 2.74% |